R. Wolfe, V. Ashby, and E. Milford, Comparison of Mortality in All Patients on Dialysis, Patients on Dialysis Awaiting Transplantation, and Recipients of a First Cadaveric Transplant, New England Journal of Medicine, vol.341, issue.23, pp.1725-1755, 1999.
DOI : 10.1056/NEJM199912023412303

P. Schnuelle, D. Lorenz, M. Trede, and F. Van-der-woude, Impact of renal cadaveric transplantation on survival in end-stage renal failure: evidence for reduced mortality risk compared with hemodialysis during long-term follow-up, J Am Soc Nephrol, vol.9, pp.2135-2176, 1998.

M. Wyld, R. Morton, A. Hayen, K. Howard, and A. Webster, A Systematic Review and Meta-Analysis of Utility-Based Quality of Life in Chronic Kidney Disease Treatments, PLoS Medicine, vol.9, issue.9, p.1001307, 2012.
DOI : 10.1371/journal.pmed.1001307.s005

J. Russell, M. Beecroft, D. Ludwin, and D. Churchill, THE QUALITY OF LIFE IN RENAL TRANSPLANTATION???A PROSPECTIVE STUDY, Transplantation, vol.54, issue.4, pp.656-60, 1992.
DOI : 10.1097/00007890-199210000-00018

Z. El-zoghby, M. Stegall, D. Lager, W. Kremers, H. Amer et al., Identifying Specific Causes of Kidney Allograft Loss, American Journal of Transplantation, vol.37, issue.3, pp.527-562, 2009.
DOI : 10.1111/j.1600-6143.2008.02519.x

J. Sellarés, D. De-freitas, M. Mengel, J. Reeve, G. Einecke et al., Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and Nonadherence, American Journal of Transplantation, vol.10, issue.2, pp.388-99, 2012.
DOI : 10.1111/j.1600-6143.2011.03840.x

M. Hourmant, Frequency and Clinical Implications of Development of Donor-Specific and Non-Donor-Specific HLA Antibodies after Kidney Transplantation, Journal of the American Society of Nephrology, vol.16, issue.9, pp.2804-2816, 2005.
DOI : 10.1681/ASN.2004121130

L. Liefeldt, S. Brakemeier, P. Glander, J. Waiser, N. Lachmann et al., Donor-Specific HLA Antibodies in a Cohort Comparing Everolimus With Cyclosporine After Kidney Transplantation, American Journal of Transplantation, vol.80, issue.Suppl 9, pp.1192-1200, 2012.
DOI : 10.1111/j.1600-6143.2011.03961.x

C. Wiebe, I. Gibson, T. Blydt-hansen, M. Karpinski, J. Ho et al., Evolution and Clinical Pathologic Correlations of De Novo Donor-Specific HLA Antibody Post Kidney Transplant, American Journal of Transplantation, vol.11, issue.5, pp.1157-67, 2012.
DOI : 10.1111/j.1600-6143.2012.04013.x

E. Rodrigo, D. Segundo, G. Fernández-fresnedo, M. López-hoyos, A. Benito et al., Within-Patient Variability in Tacrolimus Blood Levels Predicts Kidney Graft Loss and Donor-Specific Antibody Development, Transplantation, vol.100, issue.11
DOI : 10.1097/TP.0000000000001040

Y. Cottin, L. Lorgis, A. Gudjoncik, P. Buffet, C. Brulliard et al., Observance aux traitements : concepts et d??terminants, Archives of Cardiovascular Diseases Supplements, vol.4, issue.4, pp.291-298, 2012.
DOI : 10.1016/S1878-6480(12)70845-5

E. Sabaté, Adheremce to long-term therapies evidence for action, Geneva: World Health Organization, 2003.

R. Fine, Y. Becker, D. Geest, S. Eisen, H. Ettenger et al., Nonadherence Consensus Conference Summary Report, Nonadherence Consensus Conference Summary Report, pp.35-41, 2008.
DOI : 10.1111/j.1600-6143.2008.02495.x

R. Horne, S. Chapman, R. Parham, N. Freemantle, A. Forbes et al., Understanding Patients??? Adherence-Related Beliefs about Medicines Prescribed for Long-Term Conditions: A Meta-Analytic Review of the Necessity-Concerns Framework, PLoS ONE, vol.33, issue.9, p.80633, 2013.
DOI : 10.1371/journal.pone.0080633.s001

M. Dimatteo, Variations in Patients??? Adherence to Medical Recommendations, Medical Care, vol.42, issue.3, pp.200-209, 2004.
DOI : 10.1097/01.mlr.0000114908.90348.f9

T. Nguyen, A. Caze, and N. Cottrell, What are validated self-report adherence scales really measuring?: a systematic review, British Journal of Clinical Pharmacology, vol.100, issue.4, pp.427-472, 2014.
DOI : 10.1111/bcp.12194

L. Osterberg and T. Blaschke, Adherence to Medication, New England Journal of Medicine, vol.353, issue.5, pp.487-497, 2005.
DOI : 10.1056/NEJMra050100

D. Esposito, A. Bagchi, J. Verdier, D. Bencio, and M. Kim, Medicaid beneficiaries with congestive heart failure: association of medication adherence with healthcare use and costs, Am J Manag Care, vol.15, issue.7, pp.437-482, 2009.

M. Stirratt, J. Dunbar-jacob, H. Crane, J. Simoni, S. Czajkowski et al., Self-report measures of medication adherence behavior: recommendations on optimal use, Translational Behavioral Medicine, vol.34, issue.Suppl 1, pp.470-82, 2015.
DOI : 10.1007/s13142-015-0315-2

M. Dew, A. Dimartini, D. V. Dabbs, A. Myaskovsky, L. Steel et al., Rates and Risk Factors for Nonadherence to the Medical Regimen After Adult Solid Organ Transplantation, Transplantation, vol.83, issue.7, pp.858-73, 2007.
DOI : 10.1097/01.tp.0000258599.65257.a6

J. Butler, P. Roderick, M. Mullee, J. Mason, and R. Peveler, Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review, Transplantation, vol.77, issue.5, pp.769-76, 2004.
DOI : 10.1097/01.TP.0000110408.83054.88

K. Denhaerynck, F. Dobbels, I. Cleemput, A. Desmyttere, P. Schafer-keller et al., Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients: a literature review, Transplant International, vol.5, issue.10, pp.1121-1154, 2005.
DOI : 10.1097/00007890-200010270-00020

D. Geest, S. Burkhalter, H. Bogert, L. Berben, L. Glass et al., Describing the evolution of medication nonadherence from pretransplant until 3??years post-transplant and determining pretransplant medication nonadherence as risk factor for post-transplant nonadherence to immunosuppressives: The Swiss Transplant Cohort S, Transplant International, vol.17, issue.Suppl. 2, pp.657-66, 2014.
DOI : 10.1111/tri.12312

L. Couzi, B. Moulin, M. Morin, L. Albano, M. Godin et al., Factors Predictive of Medication Nonadherence After Renal Transplantation, Transplantation Journal, vol.95, issue.2, pp.326-358, 2013.
DOI : 10.1097/TP.0b013e318271d7c1

S. Takemoto, B. Pinsky, M. Schnitzler, K. Lentine, L. Willoughby et al., A Retrospective Analysis of Immunosuppression Compliance, Dose Reduction and Discontinuation in Kidney Transplant Recipients, American Journal of Transplantation, vol.2006, issue.12, pp.2704-2715, 2007.
DOI : 10.1056/NEJM199911043411906

P. Schäfer-keller, J. Steiger, A. Bock, K. Denhaerynck, D. Geest et al., Diagnostic Accuracy of Measurement Methods to Assess Non-Adherence to Immunosuppressive Drugs in Kidney Transplant Recipients, American Journal of Transplantation, vol.30, issue.3, pp.616-642, 2008.
DOI : 10.1097/00002030-200308150-00005

F. Dobbels, L. Berben, D. Geest, S. Drent, G. Lennerling et al., The Psychometric Properties and Practicability of Self-Report Instruments to Identify Medication Nonadherence in Adult Transplant Patients: A Systematic Review, Transplantation Journal, vol.90, issue.2, pp.205-224, 2010.
DOI : 10.1097/TP.0b013e3181e346cd

M. Chesney, J. Ickovics, D. Chambers, A. Gifford, J. Neidig et al., Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence Instruments, AIDS Care, vol.12, issue.3, pp.255-66, 2000.
DOI : 10.1080/09540120050042891

J. Walsh, S. Mandalia, and B. Gazzard, Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome, AIDS, vol.16, issue.2, pp.269-77, 2002.
DOI : 10.1097/00002030-200201250-00017

J. O?leary, M. Samaniego, M. Barrio, L. Potena, A. Zeevi et al., The Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant Recipients, Transplantation, vol.100, issue.1, pp.39-53, 2016.
DOI : 10.1097/TP.0000000000000869

I. Ntokou, A. Iniotaki, E. Kontou, M. Darema, M. Apostolaki et al., Long-term follow up for anti-HLA donor specific antibodies postrenal transplantation: high immunogenicity of HLA class II graft molecules, Transplant International, vol.6, issue.11, pp.1084-93, 2011.
DOI : 10.1111/j.1432-2277.2011.01312.x

M. Willicombe, P. Brookes, R. Sergeant, E. Santos-nunez, C. Steggar et al., De Novo DQ Donor-Specific Antibodies Are Associated With a Significant Risk of Antibody-Mediated Rejection and Transplant Glomerulopathy, Transplantation Journal, vol.94, issue.2, pp.172-179, 2012.
DOI : 10.1097/TP.0b013e3182543950

M. Everly, L. Rebellato, C. Haisch, M. Ozawa, K. Parker et al., Incidence and Impact of De Novo Donor-Specific Alloantibody in Primary Renal Allografts, Transplantation Journal, vol.95, issue.3, pp.410-417, 2013.
DOI : 10.1097/TP.0b013e31827d62e3

J. Cooper, J. Gralla, L. Cagle, R. Goldberg, L. Chan et al., Inferior Kidney Allograft Outcomes in Patients With De Novo Donor-Specific Antibodies Are Due to Acute Rejection Episodes, Transplantation, vol.91, issue.10, pp.1103-1112, 2011.
DOI : 10.1097/TP.0b013e3182139da1

A. Loupy, G. Hill, and S. Jordan, The impact of donor-specific anti-HLA antibodies on late kidney allograft failure, Nature Reviews Nephrology, vol.11, issue.6, pp.348-57, 2012.
DOI : 10.1038/nrneph.2012.81

J. Worthington, S. Martin, D. Husseini, P. Dyer, and R. Johnson, Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome, Transplantation, pp.1034-1074, 2003.

D. Geest, S. Abraham, I. Moons, P. Vandeputte, M. Van-cleemput et al., Late acute rejection and subclinical noncompliance with cyclosporine therapy in heart transplant recipients, J Heart Lung, vol.17, issue.9, pp.854-63, 1998.

H. Vlaminck, B. Maes, G. Evers, G. Verbeke, E. Lerut et al., Prospective Study on Late Consequences of Subclinical Non-Compliance with Immunosuppressive Therapy in Renal Transplant Patients, American Journal of Transplantation, vol.63, issue.6, pp.1509-1522, 2004.
DOI : 10.1097/00007890-199812270-00029

B. Pinsky, S. Takemoto, K. Lentine, T. Burroughs, M. Schnitzler et al., Transplant Outcomes and Economic Costs Associated with Patient Noncompliance to Immunosuppression, American Journal of Transplantation, vol.4, issue.11, pp.2597-606, 2009.
DOI : 10.1111/j.1600-6143.2009.02798.x

J. Gaynor, G. Ciancio, G. Guerra, J. Sageshima, L. Hanson et al., Graft Failure Due to Noncompliance Among 628 Kidney Transplant Recipients With Long-term Follow-up, Transplantation, vol.97, issue.9, pp.925-958, 2014.
DOI : 10.1097/01.TP.0000438199.76531.4a

T. Nevins, W. Robiner, and W. Thomas, Predictive Patterns of Early Medication Adherence in Renal Transplantation, Transplantation, vol.98, issue.8, pp.878-84, 2014.
DOI : 10.1097/TP.0000000000000148

A. Israni, F. Weng, Y. Cen, M. Joffe, M. Kamoun et al., Electronically measured adherence to immunosuppressive medications and kidney function after deceased donor kidney transplantation, Clinical Transplantation, vol.16, issue.2, pp.124-155, 2011.
DOI : 10.1111/j.1399-0012.2010.01340.x

K. Denhaerynck, F. Burkhalter, P. Schäfer-keller, J. Steiger, A. Bock et al., Clinical consequences of non adherence to immunosuppressive medication in kidney transplant patients, Transplant International, vol.16, issue.Suppl. 155, pp.441-447, 2009.
DOI : 10.1111/j.1432-2277.2008.00820.x

C. Wiebe, T. Nevins, W. Robiner, W. Thomas, A. Matas et al., The Synergistic Effect of Class II HLA Epitope-Mismatch and Nonadherence on Acute Rejection and Graft Survival, American Journal of Transplantation, vol.15, issue.8, pp.2197-202, 2015.
DOI : 10.1111/ajt.13341

D. Morisky, L. Green, and D. Levine, Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence, Medical Care, vol.24, issue.1, pp.67-74, 1986.
DOI : 10.1097/00005650-198601000-00007

K. Lamb, S. Lodhi, and H. Meier-kriesche, Long-Term Renal Allograft Survival in the United States: A Critical Reappraisal, American Journal of Transplantation, vol.3, issue.Suppl 2, pp.450-62, 2011.
DOI : 10.1111/j.1600-6143.2010.03283.x

C. Wiebe, I. Gibson, T. Blydt-hansen, D. Pochinco, P. Birk et al., Donor-Specific Antibody, American Journal of Transplantation, vol.6, issue.11, pp.2921-2951, 2015.
DOI : 10.1111/ajt.13347

L. Rostaing, A. Hertig, L. Albano, D. Anglicheau, A. Durrbach et al., Fibrosis Progression According to Epithelial-Mesenchymal Transition Profile: A Randomized Trial of Everolimus Versus CsA, American Journal of Transplantation, vol.90, issue.5, pp.1303-1315, 2015.
DOI : 10.1111/ajt.13132

G. Gupta, A. Jawdeh, B. Racusen, L. Bhasin, B. Arend et al., Late Antibody-Mediated Rejection in Renal Allografts, Transplantation, vol.97, issue.12, pp.1240-1246, 2014.
DOI : 10.1097/01.TP.0000442503.85766.91

M. Chisholm-burns, C. Spivey, R. Rehfeld, M. Zawaideh, D. Roe et al., Immunosuppressant Therapy Adherence and Graft Failure Among Pediatric Renal Transplant Recipients, American Journal of Transplantation, vol.119, issue.11, pp.2497-504, 2009.
DOI : 10.1111/j.1600-6143.2009.02793.x

T. Nevins, L. Kruse, M. Skeans, and W. Thomas, The natural history of azathioprine compliance after renal transplantation, Kidney International, vol.60, issue.4, pp.1565-1570, 2001.
DOI : 10.1046/j.1523-1755.2001.00961.x

F. Weng, Race and Electronically Measured Adherence to Immunosuppressive Medications after Deceased Donor Renal Transplantation, Journal of the American Society of Nephrology, vol.16, issue.6, pp.1839-1887, 2005.
DOI : 10.1681/ASN.2004121059

K. Denhaerynck, J. Steiger, A. Bock, P. Schäfer-keller, S. Köfer et al., Prevalence and Risk Factors of Non-Adherence with Immunosuppressive Medication in Kidney Transplant Patients, American Journal of Transplantation, vol.21, issue.1, pp.108-124, 2007.
DOI : 10.1111/j.1600-6143.2004.00427.x

D. Geest, S. Borgermans, L. Gemoets, H. Abraham, I. Vlaminck et al., INCIDENCE, DETERMINANTS, AND CONSEQUENCES OF SUBCLINICAL NONCOMPLIANCE WITH IMMUNOSUPPRESSIVE THERAPY IN RENAL TRANSPLANT RECIPIENTS, Transplantation, vol.59, issue.3, pp.340-347, 1995.
DOI : 10.1097/00007890-199502000-00006

K. Leffondre, K. Jager, J. Boucquemont, V. Stel, and G. Heinze, Representation of exposures in regression analysis and interpretation of regression coefficients: basic concepts and pitfalls, Nephrology Dialysis Transplantation, vol.29, issue.10, pp.1806-1820, 2014.
DOI : 10.1093/ndt/gft500

B. Nankivell, R. Borrows, C. Fung, O. Connell, P. Allen et al., The Natural History of Chronic Allograft Nephropathy, New England Journal of Medicine, vol.349, issue.24, pp.2326-2333, 2003.
DOI : 10.1056/NEJMoa020009

H. Ekberg, H. Tedesco-silva, A. Demirbas, ?. Vítko, B. Nashan et al., Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation, New England Journal of Medicine, vol.357, issue.25, pp.2562-2575, 2007.
DOI : 10.1056/NEJMoa067411

W. Lim, J. Eris, J. Kanellis, B. Pussell, Z. Wiid et al., A Systematic Review of Conversion From Calcineurin Inhibitor to Mammalian Target of Rapamycin Inhibitors for Maintenance Immunosuppression in Kidney Transplant Recipients, American Journal of Transplantation, vol.57, issue.9, pp.2106-2125, 2014.
DOI : 10.1111/ajt.12795

K. Budde, T. Becker, W. Arns, C. Sommerer, P. Reinke et al., Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial, The Lancet, vol.377, issue.9768, pp.837-884, 2011.
DOI : 10.1016/S0140-6736(10)62318-5

T. Isakova, H. Xie, S. Messinger, F. Cortazar, J. Scialla et al., Inhibitors of mTOR and Risks of Allograft Failure and Mortality in Kidney Transplantation, American Journal of Transplantation, vol.306, issue.1
DOI : 10.1111/j.1600-6143.2012.04281.x

D. Sawinski, J. Trofe-clark, B. Leas, S. Uhl, S. Tuteja et al., Calcineurin Inhibitor Minimization, Conversion, Withdrawal, and Avoidance Strategies in Renal Transplantation: A Systematic Review and Meta-Analysis, American Journal of Transplantation, vol.23, issue.Suppl 2
DOI : 10.1111/ajt.13710

J. Low, A. Williams, E. Manias, and K. Crawford, Interventions to improve medication adherence in adult kidney transplant recipients: a systematic review, Nephrology Dialysis Transplantation, vol.30, issue.5, pp.752-61, 2015.
DOI : 10.1093/ndt/gfu204

N. Shuker, T. Van-gelder, and D. Hesselink, Intra-patient variability in tacrolimus exposure: Causes, consequences for clinical management, Transplantation Reviews, vol.29, issue.2, pp.78-84, 2015.
DOI : 10.1016/j.trre.2015.01.002